AIkido Pharma Inc. (NASDAQ:AIKI) went down by -2.63% from its latest closing price compared to the recent 1-year high of $2.71. The company’s stock price has collected -2.63% of loss in the last five trading sessions. Press Release reported 13 hours ago that AIkido Granted Sublicense to Technology for Targeted Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients
Is It Worth Investing in AIkido Pharma Inc. (NASDAQ :AIKI) Right Now?
Plus, the 36-month beta value for AIKI is at 1.63. Opinions of the stock are interesting as 0 analysts out of 0 who provided ratings for AIkido Pharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $1802.25. AIKI currently public float of 32.96M and currently shorts hold a 1.64% ratio of that float. Today, the average trading volume of AIKI was 16.19M shares.
AIKI’s Market Performance
AIKI stocks went down by -2.63% for the week, with a monthly jump of 2.78% and a quarterly performance of 30.21%, while its annual performance rate touched 81.00%. The volatility ratio for the week stands at 5.75% while the volatility levels for the past 30 days are set at 9.82% for AIkido Pharma Inc.. The simple moving average for the period of the last 20 days is -9.24% for AIKI stocks with a simple moving average of 22.32% for the last 200 days.
AIKI Trading at -19.67% from the 50-Day Moving Average
After a stumble in the market that brought AIKI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.04% of loss for the given period.
Volatility was left at 9.82%, however, over the last 30 days, the volatility rate increased by 5.75%, as shares sank -4.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.02% lower at present.
During the last 5 trading sessions, AIKI fell by -2.63%, which changed the moving average for the period of 200-days by +43.78% in comparison to the 20-day moving average, which settled at $1.2205. In addition, AIkido Pharma Inc. saw 27.07% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for AIKI
The total capital return value is set at -32.61, while invested capital returns managed to touch -61.45. Equity return is now at value -50.70, with -49.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 31.62.